Connect with us

Covid -19

US panel approves Pfizer COVID-19 vaccine booster for over-65s, high-risk people

Published

on

US panel approves Pfizer COVID-19 vaccine booster for over-65s, high-risk people

After hours of discussion and a request to revise the question they were being asked, a key federal advisory committee on Friday recommended a third dose of the Pfizer-BioNTech COVID-19 vaccine six months after full vaccination for people aged 65 and older and those at high risk of severe COVID-19.

The initial question, posed by Pfizer, would have made the booster available to everyone aged 16 and up.

There isn’t yet sufficient evidence to show boosters for people under 65 are necessary, said members of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee.

Those at high risk would include health care workers, first responders and people likely to be exposed to the virus at work, committee members said.

Advertisement

Members said getting it right, and waiting to follow the science, were important factors.

News Source: Hindustan Times

Covid -19

Covid infection linked to more type 1 diabetes in kids and teens: Study

Published

on

By

Covid infection linked to more type 1 diabetes in kids and teens: Study

Two studies that did not definitively resolve the question of whether the coronavirus can cause the chronic disease of diabetes found that Covid-19 in children and adolescents appeared to increase the chance of acquiring diabetes. Over two years after the pandemic’s commencement, researchers from the Norwegian Institute of Public Health looked at new type 1 diabetes diagnoses using national health registries. They discovered that type 1 diabetes was roughly 60% more likely to develop in children who had tested positive for the coronavirus.

The risk within 30 days of a Covid infection confirmed by a PCR test was examined by the researchers. Young adults were also included in a Scottish study that was presented at the European Link for the Study of Diabetes meeting. This study indicated an increased risk one month following the viral sickness, but the researchers said they discovered no association after that point.

The authors of both studies emphasised that their findings do not necessarily imply a causal link between diabetes and the coronavirus. Other potential causes were emphasised, such as delays in seeking medical attention during the epidemic, the introduction of other diseases, and alterations in way of life brought on by lockdowns.

Jamie Hartmann-Boyce, an associate professor at the Nuffield department of primary care health sciences at the University of Oxford, stated: “There are a lot of plausible reasons that Covid-19 might lead to development of type 1 diabetes, but this remains in no way proved.”
According to a paper earlier this week in the medical journal The Lancet, the number of people with type 1 diabetes, in which the pancreas fails to generate the hormone insulin, may increase from 8.4 million to 17.4 million by the year 2040.

Advertisement

The illness, which has no known treatment and is most frequently diagnosed in children, is thought to be caused by a combination of genetics and exposure to particular pathogens, including SARS-Cov-2 as well as a larger family of viruses known as enteroviruses. Type 2 diabetes, which is more prevalent, typically appears later in life as sedentary habits and weight increase mess with the body’s ability to manage sugar.

Group Media Publications
Entertainment News Platforms – anyflix.in      
Construction Infrastructure and Mining News Platform – https://cimreviews.com/
General News Platform – https://ihtlive.com/
Legal and Laws News Platforms – https://legalmatters.in/
Podcast Platforms – https://anyfm.in/

Advertisement
Continue Reading
Anyskill-ads

Facebook

Trending